A large number of studies have reported that TP63 can be used as a prognostic factor for cancers such as salivary gland adenoid cystic carcinoma, anaplastic large cell lymphoma, and squamous cell carcinoma (55–58). This evidence concerns the gene TP63 and salivary gland adenoid cystic carcinoma.